Lantern Pharma Inc

LTRNNASDAQ · USD
1.08USD-0.01 (-0.47%)
125

Lantern Pharma Inc (LTRN) Implied Volatility Current

LTRN implied volatility is 321%. IV Rank is 49%, placing current premiums in the middle of their 52-week range.

Read more

Tracking LTRN implied volatility helps you identify when options premiums on Lantern Pharma Inc are historically cheap or expensive, and where the best trades are hiding. Lantern Pharma Inc implied volatility reflects the market's expectation of future price movement: when LTRN IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Lantern Pharma Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For LTRN, tracking metrics like LTRN IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on LTRN signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways.

Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where LTRN implied volatility sits today versus where it has been. Our scanner ranks Lantern Pharma Inc implied volatility against its historical range, surfaces extremes in LTRN IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Lantern Pharma Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
48.81%IV Rank
Moderate

IV is below its typical range - premiums look reasonable for buyers.

Implied Volatility (30d)320.96%

IV Rank48.81%

Historical Volatility (30d)87.62%

IV - HV+233.34%

As of September 29, 2026

Trade options with IV on your side

Track LTRN IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial